Helicobacter pylori in childhood: New insights into the immunopathogenesis of gastric disease and implications for managing infection in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 5, 1999, Pages 462-473

  Ernst, Peter B ^a   Gold, Benjamin D ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; HELICOBACTER PYLORI VACCINE; UNCLASSIFIED DRUG;

AUTOIMMUNITY; GASTRITIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH DISEASE; STOMACH LYMPHOMA;

ADULT; AUTOIMMUNITY; CHILD; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOTHERAPY; PEPTIC ULCER; STOMACH DISEASES; STOMACH NEOPLASMS;

EID: 0033499095     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199905000-00005     Document Type: Review

References (117)

1. Chan WY, Hui PK, Leung KM, Chow J, Kwok F, Ng CS. Coccoid forms of Helicobacter pylori in the human stomach. Clin Microbiol Infect Dis 1994;102:503-7.
2. Graham DY, Klein PD, Evans DJ Jr, Alpert LC, Opekun AR, Boutton TW. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1987;1174-7.
3. Staat MA, Kruzson-Moran D, McQuillan GM, Kaslow RA. A population-based serologic survey of Helicobacter. J Infect Dis 1996;174:1120-3.
4. Hoda MM, Evans DG, Evans DJ Jr, Graham DY. Helicobacter pylori in Hispanics: Comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992;103:813-6.
5. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742-5.
6. Klein PD, Graham DY, Opekun AR, O'Brian-Smith E. Water as a risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991;337:1503-6.
7. Hulten K, Han SW, Enroth H, et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996;110:1031-5.
8. Handt LK, Fox JG, Dewirst FE, et al. Helicobacter pylori isolated from the domestic cat: Public health implication. Infect Immun 1994;62:2367-74.
9. Grubel P, Hoffman JS, Chong FK, Burstein NA, Mepani C, Cave DR. Vector potential of Houseflies (Musca domestica) for Helicobacter pylori. J Clin Microbiol 1997;35:1300-3.
10. Osato MS. Houseflies are an unlikely reservoir or vector for Helicobacter pylori. J Clin Microbiol 1998;36:2786-8.
11. Mégraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995;9:(Suppl)2: 85-91.
12. Luzza F, Maletta M, Imeneo M, et al. Evidence against an increased risk of Helicobacter pylori infection in dentists: A serological and salivary study. Eur J Gastroenterol Hepatol 1995;27: 149-51.
13. Enroth H, Engstrand L. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J Clin Microbiol 1995;33:2162-5.
14. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 8390:1311-5.
15. Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987;316:1557-61.
16. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
17. Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 1990;322:359-63.
18. Yeung CK, Fu KH, Yuen KY, et al. Helicobacter pylori and associated duodenal ulcer. Arch Dis Child 1990;65:1212-6.
19. Drumm B. Helicobacter pylori in the pediatric patient. Gastroenterol Clin North Am 1993;22:169-82.
20. Blaser MJ. Helicobacter pylori: its role in disease. Clin Infect Dis 1992;15:386-91.
21. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;99(Suppl 2):45-51.
22. Rauws E, Tytgat GNJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990;337:1233-5.
23. Miehlke S, Bayerdorffer E, Lehn N, et al. Recurrence of duodenal ulcer during five years to follow up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:975-8.
24. Chong SK, Lou Q, Asnicar MA, et al. Helicobacter pylori infection in recurrent abdominal pain in childhood: Comparison of diagnostic tests and therapy. Pediatrics 1995;96:211-5.
25. Nensey YM, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991;91:15-8.
26. Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991;86:1154-7.
27. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37-43.
28. Young JL, Percy CL, Asire AJ, et al. Cancer incidence and mortality in the United States, 1973-1977. National Cancer Institute Monograph 1981;57:1-187.
29. Correa P, Fox JG, Fontham ETH, et al. Helicobacter pylori and gastric carcinoma: Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-74.
30. Recavarren-Arce S, Leon-Barua R, Cok J, et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol 1991;18:51-7.
31. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991;83: 640-43.
32. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
33. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302: 1302-5.
34. Blaser MJ, Chyou PH, Normura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995;55:562-5.
35. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
36. Huang J-Q, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori and gastric cancer. Gastroenterology 1998;114:1169-79.
37. Haenszel W, Kurihara M, Segi M, et al. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972;49:969-88.
38. McMichael AJ, McCall MG, Hartshorne JM, et al. Patterns of gastro-intestinal cancer in European migrants to Australia: The role of dietary change. Int J Cancer 1980;25:431-7.
39. Rosenwaike I. Cancer mortality among Puerto Rican-born residents in New York City. J Epidemiol 1984;119:177-85.
40. Correa P. Human gastric carcinogenesis: A multistep and multi-factorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52: 6735-40.
41. Holcombe C. Helicobacter pylori: The African enigma. Gut 1992;33:429-31.
42. Uemura N, Mukai T, Okamato S, et al. Helicobacter pylori eradication inhibits the growth of intestinal type gastric cancer in initial stage (abstract). Gastroenterology 1996;110:A282.
43. Wotherspoon AC, Ortiz, Hidalgo C, Falzon M, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
44. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996;178: 122-7.
45. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-4.
46. Censini S, Lange C, Xiang Z, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93: 14648-53.
47. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
48. Van Doorn L-J, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vagA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58-66.
49. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer. A model. Gastroenterology 1997;113:1983-91.
50. Ernst PB, Michetti P, Smith PD. The immunobiology of Helicobacter pylori. From pathogenesis to prevention. Philadelphia: Lippincott-Raven, 1997.
51. McGhee JR, Mestecky J, Detzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992;10:75-88.
52. Manganaro M, Ogra PL, Ernst PB. Oral Immunization: Turning fantasy into reality. Int Arch Allergy Appl Immunol 1994;103: 223-33.
53. Ernst PB, Crowe SE, Reyes VE. The immunopathogenesis of gastroduodenal disease associated with Helicobacter pylori infection. Curr Opin Gastroenterol 1995;11:512-8.
54. Xu-Amano BJ, Kiyono H, Jackson RJ, et al. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993;178:1309-20.
55. Kelso A. Th1 and Th2 subsets: Paradigms lost? Immunol Today 1995;16:374-9.
56. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18: 263-6.
57. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Quantitative distribution of immunoglobuin-producing cells in gastric mucosa: Relation to chronic gastritis of glandular atrophy. Gut 1986;27:505-14.
58. Wyatt JI, Rathbone BJ. Immune Response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988;23:44-9.
59. Summer F, Faller G, Konturek P, et al. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998;66:5543-6.
60. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
61. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995; 378:88-91.
62. Micallef MJ, Ohtsuki T, Kohno K, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996;26:1647-51.
63. Haeberle H, Kubin M, Bamford KB, et al. Induction of IL-12 and selection of Th1 cells in the gastric mucosa in response to H. pylori. Infect Immun 1997;65:4229-35.
64. Tarkkanen J, Kosunen TU, Saksela E. Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun 1993;61: 31012-6.
65. Fan XJ, Chua A, Shahi CN, McDevitte J, Keeling PWN, Kelleher D. Gastric T lymphocytes response to Helicobacter pylori in patients with H. pylori colonisation. Gut 1994;35:1379-84.
66. Bamford KB, Fan XJ, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-92.
67. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6:281-9.
68. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-7.
69. Karttunen R, Karttunen T, Ekre H-POT, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995;36:341-5.
70. Ernst PB, Reyes VE, Gourley WK, Haberele H, Bamford KB. Is the Th1/Th2 lymphocyte balance upset by H. pylori infection? In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic mechanisms to clinical care 1996. Lancaster, UK: Kluwer Academic Publishers, 1996:150-7.
71. D'Elios MM, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27: 1751-5.
72. Appelmelk BJ, Faller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CMJE. Bugs on trial: The case of Helicobacter pylori and autoimmunity. Immunol Today 1998;19:296-9.
73. Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-45.
74. Appelmelk BJ, Simoons-Smith I, Negrini R, et al. Potential Role molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996;64:2031-40.
75. Vollmers HP, Dammrich J, Ribbert H, et al. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer 1994;74:1525-32.
76. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Muller-Hermelink HK Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994;70:572-8.
77. Berstad AE, Brandtzaeg P, Stave R, Halstensen TS. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 1997;40:196-203.
78. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
79. Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, Covacci A. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1995;48:967-9.
80. Yamaoka Y, Kita M, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-52.
81. + strains and dissociation of gastrointestinal epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997;89:863-8.
82. Ashorn M. What are the specific features of Helicobacter pylori gastritis in children. Ann Med 1995;27:617-20.
83. Whitney AEW, Emory TS, Marty AM, et al. Macrophage infiltration of the gastric mucosa in children with and without Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1996;23: 348-55.
84. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. tumor necrosis factor α and interferon γ synergistically induce interluekin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene. J Biol Chem 1992;267:22506-11.
85. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-6.
86. Madara JL, Nash S, Parkos C. Neutrophil-epithelial cell interactions in the intestine. Adv Exp Med Biol 1991;314:329-34.
87. Curtis GH, Gall DG. Macromolecular transport by rat gastric mucosa. Am J Physiol Gastrointest Liver Physiol 1992;262: G1033-40.
88. Von Ritter C, Granger DN. Neutrophilic proteases: Mediators of formyl-methionyl-leucyl-phenylalanine-induced increase in mucosal permeability in rats. Gastroenterology 1989;97:605-9.
89. Madara JL, Patapoff TW, Gillece-Castro B, et al. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993;91:2320-5.
90. Berschnider HM, Powell DW. Fibroblasts modulate intestinal secretory responses to inflammatory mediators. J Clin Invest 1992; 89:484-9.
91. Correa P, Miller MJS. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151-62.
92. Sharma SA, Miller GG, Perez-Perez GI, Gupta RS, Blaser MJ. Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin Exp Immunol 1994;97:126-32.
93. Moss SF, Calam J, Agarwal B, Wang S, Holt PG. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38: 498-501.
94. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997;151:1695-703.
95. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants. Cancer Res 1996;56: 3238-43.
96. Wagner S, Beil W, Westermann J, et al. Regulation of epithelial cell growth both Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 1997;113:1836-47.
97. Fan XJ, Crowe SE, Behar S, et al. The effect of class II MHC expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: A mechanism for Th1 cell-mediated damage. J Exp Med 1998;187:1659-69.
98. Rudi J, Kuck F, Strand S, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 1998;102:1506-14.
99. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
100. Rabassa AA, Goodgame R, Sutton FM, Ou CN, Rognerud C, Graham DY. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996;39: 159-63.
101. Borch K, Sjostedt C, Hannestad U, Soderholm JD, Franzen L, Mardh S. Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig Dis Sci 1998;43: 749-53.
102. Vera JF, Gotteland M, Chavez E, Vial MT, Kakarieka E, Brunser O. Sucrose permeability in children with gastric damage and Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1997; 24:506-11.
103. Ruiz B, Carlton Rood J, Fontham ETH, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-9.
104. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels: Impact of eradication. Dig Dis Sci 1995;40:615-21.
105. Sobala GM, Schorah CJ, Shires S, et al. Effect of eradication of Helicobacter pylori on gastric ascorbic acid concentrations. Gut 1993;34:1038-41.
106. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996;11: 670-3.
107. Ando T, Kusugami K, Ohsuga M, et al. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect Immun 1998;66:4742-7.
108. Blanchard TG, Czinn SJ, Maurer R, Thomas WD, Soman G, Nedrud JG. urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun 1995;63:1394-9.
109. Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model. Lancet 1992;339:1120-1.
110. Michetti P, Corthesy-Theulaz I, Davin C, et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002-11.
111. Pappo J, Thomas WD, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995;63:1246-52.
112. Ghiara P, Michetti P. Development of a vaccine. Curr Opin Gastroenterol 1995;11:52-6.
113. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997;113:1848-57.
114. Saldinger PF, Porta N, Launois P, et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998;115: 891-7.
115. Ermak TH, Giannasca PJ, Nichols R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998;188:2277-88.
116. Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999;67:337-41.
117. Ernst PB. The role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther In press.